LOW
58
2
CSX
68
3
SCHW
65
-2
AMG
43
3
ABT
57
-5
GLW
48
-5
CHRW
67
3
MAT
38
-3
HSY
43
3
JCI
61
-2
STX
52
-4
BLK
70
-2
HPE
70
2
XEL
65
-2
PDCO
30
-6
VNO
60
8
ROK
67
5
STI
31
19
CMS
58
-2
LEG
31
3
LOW
58
2
CSX
68
3
SCHW
65
-2
AMG
43
3
ABT
57
-5
GLW
48
-5
CHRW
67
3
MAT
38
-3
HSY
43
3
JCI
61
-2
STX
52
-4
BLK
70
-2
HPE
70
2
XEL
65
-2
PDCO
30
-6
VNO
60
8
ROK
67
5
STI
31
19
CMS
58
-2
LEG
31
3
Financhill
Back

NeueHealth 10K Form

Sell
23

NEUE
NeueHealth

Last Price:
5.05
Seasonality Move:
-26.1%

7 Day Trial

ALL ACCESS PASS

$ 7

Key Filings

10K form not available

Receive NEUE News And Ratings

See the #1 stock for the next 7 days that we like better than NEUE

NEUE Financial Statistics

Sales & Book Value

Annual Sales: $1.16B
Cash Flow: $-29.24M
Price / Cash Flow: 0
Annual Sales: $-157.84
Price / Book: 0

Profitability

EPS (TTM): -123.68000
Net Income (TTM): $-938.16M
Gross Margin: $164.22M
Return on Equity: -3241.93%
Return on Assets: -48.48%

NeueHealth Earnings Forecast

Key NeueHealth Financial Ratios

  • The Gross Profit Margin over the past 6 years for NEUE is 14.15%.
  • The Selling, General & Administrative Expenses for NEUE have been equal to 22.33% of Gross Profit Margin.
  • The Research & Development expenses have been 1.95% of Revenue.
  • The Interest Expense is -3.32% of Operating Income.
  • The Net Earning history of NEUE is -99.19% of Total Revenues.
  • Per Share Earnings over the last 6 years have been positive in 2 years.

NeueHealth Stock Price Chart

Industry, Sector and Symbol

Stock Exchange: NYSE
Industry: Health Care Providers & Services
Sector: Health Care
Current Symbol: NEUE
Website: neuehealth.com

Debt

Debt-to-Equity Ratio: -0.3
Current Ratio: 0.75
Quick Ratio: 0.58

Price-to-Earnings

Trailing P/E Ratio: 0
Forward P/E Ratio: 0

NEUE Technical Analysis vs Fundamental Analysis

Sell
23
NeueHealth (NEUE) is a Sell

Is NeueHealth a Buy or a Sell?

  • NeueHealth stock is rated a Sell
    The current NeueHealth [NEUE] share price is $4.66. The Score for NEUE is 23, which is 54% below its historic median score of 50, and infers higher risk than normal.